Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes.
The proline-rich region of 18.5-kDa myelin basic protein binds to the SH3-domain of Fyn tyrosine kinase with the aid of an upstream segment to form a dynamic complex in vitro.
Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.
Therapeutic Cleavage of Anti-Aquaporin-4 Autoantibody in Neuromyelitis Optica by an Igg-Selective Proteinase.
Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis.
Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.
In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis.
Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.
Addressing the regulatory and scientific challenges in multiple sclerosis - a statement from the EU regulators.
Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood-brain barrier under physiologic and neuroinflammatory conditions.
Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity.
Time-to-Contact Analysis of Gait Stability in the Swing Phase of Walking in People With Multiple Sclerosis.
Highlights From the 2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)-European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
IMMUNE SYSTEM INDUCTION OF NERVE GROWTH FACTOR IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS: IMPLICATIONS IN RE-MYELINATION AND MYELIN REPAIR.
Cognitive-Motor Interference in Multiple Sclerosis: A Systematic Review of Evidence, Correlates, and Consequences.
Magnetic susceptibility contrast variations in multiple sclerosis lesions.
Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.
Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too.
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
Pangaea 2.0: State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod.
Long-distance effects of inflammation on differentiation of adult spinal cord neural stem/progenitor cells.
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
The magnetic resonance imaging 'rule of five': predicting the occurrence of relapse.
Label-free imaging to study phenotypic behavioural traits of cells in complex co-cultures.

Pages